HURA TuHURA Yalpi foyda normasi

TuHURA Biosciences, Inc. (HURA) kompaniyasining rasmiy ramzlari

TuHURA Biosciences, Inc. (HURA) shaxsiylashtirilgan saraton vaksinalarini tijoratlashtirish orqali daromad keltiradi. Hozirgi vaqtda, yuqori R&D xarajatlari kompaniyani rivojlanishning foyda olmagan bosqichida ushlab turibdi. Daromadning foiz ko'rsatkichi sifatidagi yalpi foyda marjasi rentabellikning tiklanish sur'atini aks ettiradi, bunda 0.00 metriki ushbu darajani belgilaydi. Shu bilan birga, dori-darmonlarni ishlab chiqish AI yordamida avtomatlashtirilgan, ammo yakuniy testlar shifokor nazoratini talab qiladi.

TuHURA (HURA) Yalpi foyda bo'yicha rentabellik: 04.07.2022 - 20.11.2026 davri uchun

TuHURA Biosciences, Inc. (HURA) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Kompaniyaning asosiy tahlili:HURA tuhurabio.com
TuHURA tayyor mahsulotlari

Yalpi foyda bevosita ishlab chiqarish xarajatlaridan keyin qolgan tushum qismini belgilaydi, bu esa aktivning operatsion modelining fundamental samaradorligi va narx belgilash imkoniyatlarini baholash imkonini beradi. TuHURA Biosciences, Inc. (HURA) yalpi foydasining barqarorligi tahlili biznesning ichki daromadliligini ochib beradi, bu esa onkologiya sektorida makrotsikllardan katta darajada mustaqildir, chunki innovatsion terapiyaga bo'lgan talab faqat klinik sinovlarning muvaffaqiyati bilan belgilanadi.

Asosiy raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|protaratx.com - Yalpi marja|FATE - Yalpi marja|WHWK: Yalpi marja|TScan Therapeutics (TCRX) - Yalpi marja|Yalpi rentabellik Champions Oncology|Yalpi rentabellik XBIT|Yalpi marja CVM|Yalpi foyda bo'yicha rentabellik OS Therapies Inc. OSTX|Yalpi rentabellik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Yalpi foyda marjasi|ANL - Yalpi rentabellik|Yalpi foyda marjasi verupharma.com|TPST: Yalpi marja|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik